| Application no. and date | 21769080.9 (espacenet) (Federated) (European Patent Register), 20210820 | | Patent/reg. no. and date | DK/EP 4138818, 20240821 | | Publication date | 20230301 | | Priority no. and date | US 202017006115, 20200828, GB 202013571, 20200828 | | EP pub. no. and date |
EP 4138818 20230301 | | Effective date | | | Applicant/owner | Cybin UK Ltd, Golden Cross House
8 Duncannon Street
London WC2N 4JF, GB | | Applicant ref. no. | | | Inventor | LAYZELL, Marie Claire,
London EC2A 4BX, GB,
RENNIE, James Maxwell,
London EC2A 4BX, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/4045 (2006.01) , A61K 47/12 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 25/22 (2006.01) | | Title | INJECTABLE FORMULATION | | Int. application no. | EP2021073189 | | Int. publication no. | WO2022043227 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
